Steris Plc (STE31) Growth Rates Comparisons to Medical Equipment & Supplies Industry, Sector, Market. Sales, Income, EPS
CSIMarket
 
Steris Plc  (NYSE: STE31)
 

Steris Plc Growth Comparisons

Select each growth Category to receive further Information





STE31 Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) 23.29 % 9.27 % 0.53 % 5.63 %
Q / Q Revenue Growth (Q2 MRQ) 34.18 % 6.72 % 2.95 % 0.88 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) 3.55 % 4.63 % 4.07 % %
Sequential Revenue Growth (for 12 months ending Q2 TTM) 6.32 % 1.24 % -0.32 % 1.48 %
Revenue 5 Year Average Growth - 7.62 % 8.94 % 9.55 %


STE31's Growth Comparisons in I. Quarter 2026




With 23.29% year on year Revenue increase in the first quarter 2026, Steris Plc outperformed the 9.27% growth in the Medical Equipment & Supplies industry, and 0.53% growth in the Healthcare sector. Comparing the first quarter sales growth, both Medical Equipment & Supplies industry and Steris Plc outperformed 5.63% overall market increase.

Company's sequential top-line increase was 34.18% from the third quarter. Average annual sales rise for Steris Plc is %, while S & P 500's average yearly sales growth is 9.55% over the five years, including only Businesses with the first quarter 2026 Results.


Growth Rates of STE31's Income in the first quarter 2026


STE31 Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) 211.13 % -39.05 % -6.36 % -20.07 %
Sequential Operating Income Change (Q2 MRQ) 49.79 % 7 % 15.08 % -6.72 %
Y / Y Operating Income Growth (Q2 TTM) -22.8 % -28.46 % -16.46 % 3.51 %
Sequential Operating Income Growth (Q2 TTM) 144.04 % -8.98 % -10.02 % -5.38 %
Operating Income 5 Year Avg. Change - -3.47 % 4.67 % 8.71 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) 286.14 % -37.64 % -37.68 % -21.04 %
Sequential Income from Cont. Ops. Change (Q2 MRQ) 62.98 % 87.82 % -15.34 % -17.27 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) -50.65 % -46.27 % -40.5 % -3.14 %
Sequential Income from Cont. Ops. Change (Q2 TTM) - -15.29 % -24.41 % -5.49 %
Income from Cont. Ops. 5 Year Avg. Change - -1.89 % 8.32 % 11.88 %

STE31 Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) 286.14 % -49.67 % -36.79 % -19.16 %
Q / Q Net Income Growth (Q2 MRQ) 62.98 % 50.01 % -18.46 % -15.62 %
Y / Y Net Income Change (Q2 TTM) -50.65 % -46.02 % -40.05 % -4.05 %
Sequential Net Income Change (Q2 TTM) - -15.09 % -23.96 % -5.07 %
Net Income 5 Year Avg. Growth - -2.75 % 10.49 % 3.58 %

STE31's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) 279.63 % -37.43 % -37.68 % -21.04 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ) 55.3 % 102.76 % -15.34 % -17.27 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) 137.7 % - - -
Sequential EPS from Cont. Ops. Change (Q2 TTM) 35.2 % - - -36.1 %
EPS from Cont. Ops. 5 Year Avg. Growth - -12.8 % 8.32 % 11.88 %



STE31 EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) 284.91 % -49.5 % -36.79 % -19.16 %
Q / Q EPS Net Growth (Q2 MRQ) 64.52 % 61.94 % -18.46 % -15.62 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - -99.83 %
Sequential EPS Net Change (for 12 months ending Q2 TTM) - - - -99.83 %
EPS Net 5 Year Avg. Change - -2.75 % 10.49 % 3.58 %



Despite the -49.5% decline in Medical Equipment & Supplies industry, Steris Plc showed impressive surge in EPS in the first quarter by 284.91% from the same quarter a year ago, to $2.04, Healthcare sector dropped -36.79%. Despite modest earnings per share in the Medical Equipment & Supplies industry and ind the Healthcare sector, Steris Plc reported above average market earnings per share growth.

The bottom-line grew by 64.52% from the third quarter. Average yearly income per share growth for Steris Plc is %, while S & P 500's average annual income per share increase is 3.58% over the five years, including only Businesses with the first quarter 2026 earnings reports.

STE31 Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) 183.4 % -20.97 % -11.7 % -2.5 %
Sequential Free Cash Flow Change (Q2 MRQ) 145.78 % 24.17 % 2.3 % 26.14 %
Y / Y Free Cash Flow Change (Q2 TTM) 33.48 % -39.73 % -12.84 % 0.31 %
Sequential Free Cash Flow Change (Q2 TTM) 51.8 % -3.73 % 27.55 % -2.58 %
Free Cash Flow 5 Year Avg. Change - -4.06 % 6.34 % -24.89 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - - - -
Sequential Net Cash Flow Change (Q2 MRQ) - - - -
Y / Y Net Cash Flow Change (Q2 TTM) - - - -
Sequential Net Cash Flow Change (Q2 TTM) - - - -
Net Cash Flow 5 Year Avg. Change - - -32.87 % 34.23 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) 19.74 % -0.95 % -6.1 % 0.91 %
Sequential Capital Expenditures Change (Q2 MRQ) -4.7 % 6.06 % 14.45 % 90.44 %
Y / Y Capital Expenditures Change (Q2 TTM) 31.46 % 5.23 % 11.11 % 0.15 %
Sequential Capital Expenditures Change (Q2 TTM) 3.97 % 3.82 % 8.26 % -1.55 %
Capital Expenditures 5 Year Avg. Change - 10.45 % 9.54 % 8.63 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.